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Mouse hepatitis virus (MHV) infection in murine 17Cl-1 cells results in apoptotic cell death. Inhibition of MHV-induced
apoptosis by the pancaspase inhibitor Z-VAD-FMK promoted virus production late in infection, indicating that apoptosis could
be a host response to limit the production of viral progeny. Activation of the mitochondria-mediated apoptotic pathway was
indicated by the activation of caspase-9 and delay of apoptosis by Bcl-2 overexpression. Analyses of the subcellular
distribution of cytochrome c, procaspase-9, and Apaf-1 suggested an aberrant apoptosome formation in the vicinity of the
mitochondria, which could be a cell type-specific event. An increase in the amount of Fas (APO-1/CD95), caspase-8
activation, caspase-8-mediated Bid cleavage, and subsequent translocation of truncated Bid to mitochondria, all of which
relate to the Fas-mediated pathway, also occurred in MHV-infected 17Cl-1 cells, whereas the formation of the death-inducing
signaling complex, a direct indication of the activation of Fas-mediated pathway, was undetectable. Caspase-8 and Bid
activation appeared to be downstream of mitochondria, because Bcl-2 overexpression suppressed both events, suggesting
that infected 17Cl-1 cells might have activated a receptor-mediated “type II” signaling pathway, in which primary and low
levels of receptor-mediated pathway activation lead to the activation of the mitochondria-mediated pathway. All our dataINTRODUCTION
Viral infection may trigger a variety of host cellular
responses, and one outcome of virus–host interaction is
the activation of an innate cell death machinery, called
programmed cell death, or apoptosis; many viruses and
viral proteins are capable of inducing apoptosis (re-
viewed by O’Brien, 1998; Teodoro and Branton, 1997).
The induction of apoptosis upon viral infection has been
hypothesized to be a host-defense response, since early
death of virus-infected cells would prevent viral replica-
tion. Many viruses have developed a countermeasure(s)
that effectively blocks or delays cell death by expressing
antiapoptotic proteins to maximize the production of viral
progeny (reviewed by Hardwick, 1998; O’Brien, 1998; Te-
odoro and Branton, 1997). On the other hand, apoptosis
induction at the end of the viral replication cycle might
assist in viral dissemination, while attenuating an inflam-
matory response. Apparently viruses have evolved to
regulate apoptosis, which may directly or indirectly con-
tribute to viral pathogenesis.
Apoptosis usually involves the activation of a family of
cysteine proteases named caspases, which cleave a
1 To whom reprint requests should be addressed at Department of
Microbiology and Immunology, The University of Texas Medical Branch321variety of cellular substrates, and the cleavage of certain
important protein targets leads to detrimental biochem-
ical and morphological changes and eventual cell de-
struction (reviewed by Earnshaw et al., 1999; Nicholson,
1999). Caspases are synthesized as proenzymes, which
require cleavage for their activation. Initiator caspases,
such as caspase-8 and -9, undergo self-cleavage and
activation upon receiving apoptotic signals. These up-
stream caspases then activate effector caspases, such
as caspase-3, -6, and -7, which execute the cleavage of
other cellular substrates. Caspase cascades can be ac-
tivated by two major pathways. In one pathway, different
stimuli converge death signals to mitochondria, resulting
in mitochondrial damage and the release of cytochrome
c to the cytoplasm, where it forms apoptosome com-
plexes with Apaf-1 and procaspase-9 in the presence of
dATP, leading to the activation of caspase-9 (Li et al.,
1997; Saleh et al., 1999; Zou et al., 1999). The other
pathway initiates from cell surface death receptors, such
as Fas (CD95/APO-1) and TNF-R1. Engagement of these
receptors by their cognate ligands results in the aggre-
gation of intracellular death domains and the recruitment
of FADD and procaspase-8, forming the death-inducing
signaling complex (DISC), where caspase-8 is activated
(Kischkel et al., 1995; Medema et al., 1997).indicate that a mitochondria-mediated pathway played a m
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Bcl-2 family proteins play an important role in regulat-
ing apoptotic signaling at the mitochondrial level (re-
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viewed by Adams and Cory, 1998; Gross et al., 1999).
Antiapoptotic members Bcl-2 and Bcl-XL inhibit cyto-
chrome c release, while proapoptotic members Bax, Bak,
Bid, and Bik promote cytochrome c release (Finucane et
al., 1999; Jurgensmeier et al., 1998; Kluck et al., 1997;
Shimizu and Tsujimoto, 2000; Yang et al., 1997). Bid, a
22-kDa “BH3-domain-only” member, is cleaved by
caspase-8, and the 15-kDa truncated Bid fragment (p15
tBid) translocates to mitochondrial membranes, where it
triggers the homooligomerization of Bak and Bax, result-
ing in the release of cytochrome c from mitochondria
(Eskes et al., 2000; Wei et al., 2000, 2001). Hence Bid
plays a role in amplifying receptor-mediated death sig-
nals by activating the mitochondrial pathway (Li et al.,
1998; Luo et al., 1998).
Coronaviruses are enveloped RNA viruses that
cause gastrointestinal and upper respiratory tract ill-
nesses in animals and humans (Perlman, 1998; Wege
et al., 1982). Among coronaviruses, mouse hepatitis
virus (MHV) is one of the best characterized in terms of
its pathogenesis and molecular biology. MHV causes
various diseases, including hepatitis, enteritis, and
encephalitis, in rodents (Compton et al., 1993; Wege et
al., 1982). In addition, infection with certain strains of
MHV causes demyelination in rodents, and MHV-
induced demyelination has been used as an excellent
model system for human demyelinating diseases,
such as multiple sclerosis (Bailey et al., 1949; Hout-
man and Fleming, 1996; Wege et al., 1982). It has been
reported that coronaviruses, including MHV (An et al.,
1999; Belyavsky et al., 1998), transmissible gastroen-
teritis coronavirus (TGEV) (Eleouet et al., 1998, 2000),
and infectious bronchitis virus (IBV) (Liu et al., 2001)
can cause caspase-dependent apoptotic cell death in
infected cultured cells. TGEV infection may lead to
apoptosis via cellular oxidative stress (Eleouet et al.,
1998), and TGEV N protein is a substrate for caspase-6
and -7 (Eleouet et al., 2000). Some coronavirus pro-
teins, such as a 58-kDa protein encoded by IBV open
reading frame 1b and MHV E protein, trigger apoptosis
when they are overexpressed (An et al., 1999; Liu et al.,
2001).
MHV replication in murine fibroblast 17Cl-1 cells
induces apoptosis (An et al., 1999). The present study
characterized the molecular mechanisms leading to
the activation of apoptotic pathways in MHV-infected
17Cl-1 cells. Analyses of subcellular localization of
cytochrome c, Apaf-1, and caspase-9 suggested an
unusual event of apoptosome formation in association
with mitochondria in infected 17Cl-1 cells. Character-
ization of the effect of overexpressed Bcl-2 and the
status of various caspases and Bid demonstrated that
mitochondria act as a critical regulator in MHV-
induced apoptosis.
RESULTS
Effect of the pancaspase inhibitor Z-VAD-FMK on
MHV-induced apoptosis and virus growth
To discover the biological significance of MHV-in-
duced apoptosis in 17Cl-1 cells, we examined the effect
of the broad-range caspase inhibitor Z-Val-Ala-Asp-fmk
(Z-VAD-FMK) on MHV-induced apoptosis and MHV rep-
lication. Addition of 150 M Z-VAD-FMK to 17Cl-1 cells
that were infected with the A59 strain of MHV (MHV-A59)
inhibited the production of apoptotic DNA fragments (Fig.
1A). MHV-A59 infection causes extensive cell fusion in
17Cl-1 cells (An et al., 1999); almost all fused cells detach
from the culture dish after 20 h postinfection (p.i.). MHV
infection still caused syncytia in the presence of Z-VAD-
FMK, yet most of the fused cells remained adherent on
the culture dish for up to 48 h, the end point of the
experiments. These data demonstrated that MHV-A59-
induced apoptosis was executed by caspase-dependent
mechanisms, and suppression of apoptosis affected
MHV-induced cytopathogenicity.
We next examined the effect of apoptosis on MHV
production. As shown in Fig. 1B, in the absence of the
caspase inhibitor, the highest virus titer in the culture
fluid of infected 17Cl-1 cells was detected at 12 h p.i., and
the titer gradually decreased. In contrast, in the presence
of Z-VAD-FMK, infected 17Cl-1 cells continuously pro-
duced a higher MHV titer from 16 to 36 h p.i. (at 24, 30,
and 36 h p.i., Student’s t test, P  0.001). To eliminate
the possibility that MHV was stabilized in the presence of
Z-VAD-FMK, culture fluid of MHV-infected cells, which
was obtained at 20 h p.i., was incubated with 150 M
Z-VAD-FMK or without Z-VAD-FMK at 37°C for another
44 h. A similar MHV titer was obtained in both samples
(data not shown), demonstrating that Z-VAD-FMK did not
affect the stability of MHV. These data demonstrated that
when apoptosis was suppressed, the virus titer re-
mained at a high level, even at the late stage in infection.
Bcl-2 overexpression delays MHV-induced apoptosis
The antiapoptotic Bcl-2 protein has been known to
block apoptosis by maintaining the integrity of mitochon-
drial membranes and preventing the release of apopto-
sis-activating factors, such as cytochrome c and apop-
tosis-inducing factor (AIF), from mitochondria (Kluck et
al., 1997; Susin et al., 1999b; Yang et al., 1997). To deter-
mine whether the mitochondria-mediated pathway was
activated during MHV-induced apoptosis, we examined
the effect of Bcl-2 overexpression on MHV-induced apop-
tosis. Three 17Cl-1 cell lines that stably overexpressed
Bcl-2 (17Cl-1/bcl-2) and two control 17Cl-1 cell lines that
stably expressed the neomycin phosphotransferase
gene (17Cl-1/neo) were established. These cells were
infected with MHV-A59 or mock infected. MHV-infected
17Cl-1/neo and 17Cl-1/bcl-2 cells showed syncytia for-
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mation, as seen in MHV-infected parental 17Cl-1 cells.
The infected 17Cl-1/neo cells started to detach from the
culture dish after 14 h p.i., whereas the majority of in-
fected 17Cl-1/bcl-2 cells remained attached to the dish
for up to 24 h p.i. At 18 h p.i., cells were collected and
suspended in staining solutions containing propidium
iodide. Nuclear DNA was stained by propidium iodide
and the samples were applied for flow cytometric anal-
ysis, in which the proportion of nuclei containing subdip-
loid DNA contents, i.e., apoptotic nuclei, was determined.
As shown in Fig. 2A, MHV-induced apoptosis was
blocked in all three 17Cl-1/bcl-2 cell lines, but not in both
17Cl-1/neo cell lines. However, when the cultures were
incubated further, infected 17Cl-1/bcl-2 cells became de-
tached from the culture dish late in infection (data not
shown). Consistent with the observed cytopathogenicity,
accumulation of apoptotic DNA fragments occurred in
infected 17Cl-1/bcl-2 cells at 32 h p.i. (Fig. 2B, top panel,
lanes 2 and 5), indicating that MHV-infected 17Cl-1/bcl-2
cells eventually died by apoptosis. Western blot analysis
of Bcl-2 protein revealed the appearance of an additional
band with an approximate molecular weight of 23 kDa
(Bcl-2) in infected 17Cl-1/bcl-2 cells, but not in unin-
fected cells (Fig. 2B, bottom panel). It is known that Bcl-2
can be cleaved by caspase-3, producing a 23-kDa pro-
teolytic fragment (Cheng et al., 1997). Treatment of Z-
VAD-FMK blocked both apoptosis and Bcl-2 cleavages
(Fig. 2B, lanes 3 and 6), suggesting that certain
caspases, probably caspase-3, cleaved Bcl-2 late in in-
fected 17Cl-1/bcl-2 cells. The finding that overexpression
of Bcl-2 delayed MHV-induced apoptosis indicated the
involvement of the mitochondria-mediated pathway in
MHV-induced cell death in 17Cl-1 cells.
Activation of the mitochondrial pathway in the
absence of cytochrome c release in MHV-infected
17Cl-1 cells
To further demonstrate the activation of the mitochon-
dria-mediated pathway, we analyzed two hallmarks of
this pathway, cytochrome c release from mitochondria
and caspase-9 activation (Kluck et al., 1997; Li et al.,
1997; Yang et al., 1997; Zou et al., 1997). Etoposide, a
topoisomerase II inhibitor, induces apoptosis by activat-
ing the mitochondria-mediated pathway (Kluck et al.,
1997; Yang et al., 1997); hence etoposide-treated 17Cl-1
cells served as positive controls. Western blot analysis
showed that procaspase-9 was processed into a 35-kDa
FIG. 1. Effect of Z-VAD-FMK on MHV-induced apoptosis (A) and MHV yield (B). (A) The 17Cl-1 cells were mock infected (lane 2) or infected with MHV
at a multiplicity of infection (m.o.i.) of 5 in the presence (lane 4) or the absence (lane 3) of Z-VAD-FMK. At 24 h p.i., low-molecular-weight DNA was
extracted and separated in a 2% agarose gel; lane 1, DNA size markers. (B) The 17Cl-1 cells were infected with MHV at an m.o.i. of 5 in the presence
(filled circles) or the absence (open circles) of Z-VAD-FMK. Culture fluids were collected at indicated times p.i., and MHV titers were determined by
plaque assays. The results are expressed as the means of four independent experiments.
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fragment (p35) and a 37-kDa fragment (p37) at 16 and
20 h p.i. (Fig. 3A). No procaspase-9 cleavage occurred in
mock-infected cells. p35 is known to be produced by
autocleavage of procaspase-9 when the apoptosome
complex is formed, while p37 is produced by caspase-
3-mediated cleavage of procaspase-9 (Srinivasula et al.,
1998). The appearance of p35 in infected cells demon-
strated activation of the mitochondrial pathway.
We next examined whether cytochrome c was re-
leased from mitochondria to cytoplasm in MHV-infected
17Cl-1 cells. Mitochondrial and cytosolic fractions were
prepared by subcellular fractionation and probed for cy-
tochrome c by Western blot analysis. To our surprise,
most of the cytochrome c remained in the mitochondria
at 16 h p.i., and no significant amounts of cytochrome c
were released into the cytosol (Fig. 3B, lanes 3 and 4); at
this time postinfection, caspase-9 activation was evident
(Fig. 3A, lane 3; Fig. 3B, lanes 3 and 4). The same
phenomenon was also observed in etoposide-treated
17Cl-1 cells (Fig. 3B, lanes 5 and 6). In more than 20
repetitions of the experiments with numerous experi-
mental modifications, we did not obtain clear evidence
for the release of cytochrome c into cytosol. Immunoflu-
orescence analysis of infected cells using anti-cyto-
chrome c antibodies also failed to demonstrate the re-
lease of cytochrome c into the cytosol (data not shown).
Hence, we concluded that the release of cytochrome c
from mitochondria into the cytosol did not occur in either
MHV-infected or etoposide-treated 17Cl-1 cells.
Association of cytochrome c with mitochondria led us
to explore a possibility that the apoptosome complex
may be formed in the vicinity of mitochondria in apoptotic
17Cl-1 cells. As shown in Fig. 3B, procaspase-9 was
found in both mitochondria and cytoplasm in mock-in-
fected cells (Fig. 3B, lanes 1 and 2). Notably, in both
MHV-infected and etoposide-treated 17Cl-1 cells, the
majority of mitochondria-associated procaspase-9 un-
derwent cleavage, and the autocleavage fragment, p35,
was detected in the mitochondrial fractions (Fig. 3B,
lanes 3 and 5), suggesting that apoptosome might have
been formed in a location associated with mitochondria.
The caspase-9 cleavage fragment p37 was also present
in the mitochondria of MHV-infected 17Cl-1 cells (Fig. 3B,
lane 3), indicating that caspase-3-mediated cleavage of
procaspase-9 occurred in the mitochondria. If apopto-
some is formed in a location associated with mitochon-
dria, then Apaf-1, another component of the apoptosome
complex, should be detected in the mitochondrial frac-
tion. In mock-infected nonapoptotic 17Cl-1 cells, a sig-
nificant amount of Apaf-1 was detected in the mitochon-
drial fraction (Fig. 3B, lane 1), while there was a clear
decrease in the amount of mitochondrial Apaf-1 in MHV-
infected cells (Fig. 3B, lane 3). The decrease of mitochon-
drial Apaf-1 in infected 17Cl-1 cells could be due to
caspase-3-mediated cleavage, as reported previously
(Lauber et al., 2001). Although we did not examine the
subcellular localization of caspase-3, it is known that
procaspase-3 has a cytosolic and mitochondrial distri-
bution in nonapoptotic cells (Mancini et al., 1998). It is
possible that the mitochondrial apoptosome formation
may directly lead to the activation of mitochondria-asso-
ciated procaspase-3 in MHV-infected 17Cl-1 cells. In
FIG. 2. Effect of Bcl-2 overexpression on MHV-induced apoptosis. (A)
The 17Cl-1/bcl-2 and 17Cl-1/neo cell clones were mock infected (blank
bars) or infected with MHV (filled bars) at an m.o.i. of 10. Cells were
collected at 18 h p.i., and the populations of apoptotic nuclei with
subdiploid DNA contents were determined as described under Mate-
rials and Methods. The results are expressed as the means of two
independent experiments. (B) Two 17Cl-1/bcl-2 cell clones (clones 3
and 7) were mock infected (lanes 1 and 4) or infected with MHV at an
m.o.i. of 10 in the presence (lanes 3 and 6) or the absence (lanes 2 and
5) of Z-VAD-FMK. At 32 h p.i., low-molecular-weight DNA was extracted
and analyzed by electrophoresis in a 2% agarose gel (top), and total cell
lysates were subjected to Western blot analysis and probed for Bcl-2
(bottom).
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contrast, active caspase-3 appeared to be absent in
mitochondria of etoposide-treated 17Cl-1 cells, because
the mitochondrial fraction lacked caspase-9 cleavage
fragment p37 (Fig. 3B, lane 5) and cleavage of Apaf-1
was not evident in the mitochondrial fraction of etopo-
side-treated 17Cl-1 cells. Detection of p37 in the cyto-
plasm of etoposide-treated 17Cl-1 cells suggested that
active caspase-3 was present in the cytoplasm (Fig. 3B,
lane 6). The absence of caspase-9 cleavage fragment
p37 in the mitochondrial fraction of etoposide-treated
cells (Fig. 3B, lane 5) demonstrated that the contamina-
tion of cytosolic proteins in the mitochondrial fractions
was negligible under our experimental conditions. It is
unclear why mitochondria-associated caspase-3 ap-
peared to be activated in MHV-infected 17Cl-1 cells, but
not in etoposide-treated 17Cl-1 cells.
Taken together, our results suggested that activation
of the mitochondrial pathway in 17Cl-1 cells occurred
without the release of cytochrome c from mitochondria to
cytoplasm. Mitochondrial pathway activation in 17Cl-1
cells appeared to involve an unusual formation of apop-
tosome complex in the vicinity of the mitochondria, pos-
sibly in the intermembrane space or on the outer mem-
brane of mitochondria. This unique phenotype of mito-
chondrial pathway activation seems to be cell type
specific, rather than stimuli specific. We have tried to
further characterize this phenomenon by treating 17Cl-1
cells with staurosporine, a broad-range protein kinase
inhibitor that induces apoptosis in other cell types
through the activation of the mitochondrial pathway
(Kluck et al., 1997; Yang et al., 1997). However, treatment
of 17Cl-1 cells with 5 M staurosporine for 24 h did not
FIG. 3. Activation of the mitochondrial pathway in the absence of mitochondrial cytochrome c release in MHV-infected 17Cl-1 cells. (A) Caspase-9
activation in MHV-infected 17Cl-1 cells. The 17Cl-1 cells were mock infected (lanes 5 and 6) or infected with MHV at an m.o.i. of 10 (lanes 1–4). Cell
lysates were collected at the indicated times p.i., and equal amounts of protein (40 g) from each sample were subjected to Western blot analysis
and probed for caspase-9. (B) Subcellular localization of cytochrome c, caspase-9, and Apaf-1 in 17Cl-1 cells infected with MHV or treated with
etoposide. The 17Cl-1 cells were mock infected (Mock), infected with MHV (MHV), or treated with etoposide (Etoposide). At 16 h p.i. and 18 h after
etoposide treatment, cells were collected and subjected to subcellular fractionation. Twenty-five micrograms of protein from each of the mitochondrial
(Mito.) or cytosolic (Cyto.) fractions was subjected to Western blot analysis and probed for cytochrome c, caspase-9, Apaf-1, and actin.
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cause cell death (data not shown). Another apoptosis
inducer, dexamethasone, also failed to induce apoptosis
in 17Cl-1 cells (data not shown). Our results indicate that
17Cl-1 cells, a spontaneously transformed cell line de-
rived from BALB/c 3T3 cells, have aberrant responses to
apoptotic stimuli.
Caspase-8 activation and Bid cleavage during MHV-
induced apoptosis
Although Bcl-2 overexpression delayed MHV-induced
apoptosis, caspase-dependent Bcl-2 cleavage and apop-
tosis eventually occurred in MHV-infected 17Cl-1/bcl-2
cells (Fig. 2). These data suggested that either the accu-
mulation of proapoptotic signals overcame the antiapop-
totic function of Bcl-2 later in infection or a Bcl-2-insen-
sitive pathway, i.e., other than the mitochondrial pathway,
might also have been activated, leading to caspase-3
activation and subsequent Bcl-2 cleavage. Since recep-
tor-mediated apoptosis is Bcl-2-insensitive, we then in-
vestigated whether any receptor-mediated pathway was
activated during MHV-induced apoptosis. We first exam-
ined the activation of caspase-8, an apical caspase that
is activated in death receptor-mediated apoptosis. As
shown in Fig. 4A, procaspase-8 was cleaved into the p18
fragment late in infection. Furthermore, a colorimetric
substrate assay for caspase-8 also demonstrated the
activation of caspase-8 (Fig. 4B).
Bid, the “BH3-domain-only” pro apoptotic Bcl-2 mem-
ber, can be cleaved by caspase-8 (Li et al., 1998; Luo et
al., 1998), and the p15 tBid targets mitochondria, causing
mitochondrial damage and activating the mitochondria-
mediated pathway (Eskes et al., 2000; Wei et al., 2000,
2001); hence we next examined the presence of Bid
cleavage in infected cells. As shown in Fig. 5A, p15 tBid
started to appear at 12 h p.i., and the amounts of p7 and
p15 tBid fragments increased later in the course of the
infection. Characterization of the subcellular localization
of tBid clearly demonstrated that the majority of both p15
and p7 tBid fragments localized in the mitochondrial
fraction (Fig. 5B), which is consistent with previous find-
FIG. 4. Caspase-8 activation in MHV-infected 17Cl-1 cells. (A) The 17Cl-1 cells were mock infected (lanes 1 and 2) or infected with MHV at an m.o.i.
of 10 (lanes 3–6). Cell lysates were collected at the indicated times p.i., and equal amounts of protein (40 g) from each sample were subjected to
Western blot analysis and probed for caspase-8. (B) Cell lysates were collected at indicated times p.i. and subjected to a colorimetric caspase-8
activity assay as described under Materials and Methods. The results are expressed as the means of two independent experiments.
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ings by others that p7 and p15 fragments form a tight,
noncovalent complex after cleavage by caspase-8 (Chou
et al., 1999; Zha et al., 2000), and myristoylated p15
inserts into mitochondrial membranes (Zha et al., 2000).
These data indicated that the translocation of tBid to
mitochondria was one of the mechanisms that activated
the mitochondrial pathway in MHV-infected 17Cl-1 cells.
Furthermore, caspase-8 activation and Bid cleavage sug-
gested the activation of a cell surface death receptor(s)
during MHV-induced apoptosis.
Bcl-2 overexpression suppresses caspase-8
activation and Bid cleavage in infected 17Cl-1 cells
To know whether the receptor-mediated pathway was
activated in MHV-infected 17Cl-1 cells, a multiprobe
RNase protection assay (mAPO-3 template set, Ribo-
Quant multiprobe RNase protection assay system, BD
Pharmingen) was used to examine the expression of a
panel of genes whose products can regulate receptor-
mediated apoptosis. The amount of mRNAs for
caspase-8, Fas ligand, FADD, FAP-1, FAF-1, TRAIL, TN-
FRp55, TRADD, and RIP did not change during the
course of MHV replication in 17Cl-1 cells, whereas a
significant increase (about 20-fold) in the amount of Fas
mRNA and a moderate increase (about 3-fold) in the
amount of Fas protein occurred from 12 to 24 h p.i. (data
not shown), suggesting a possible activation of the Fas-
mediated pathway in MHV-infected 17Cl-1 cells. How-
ever, anti-Fas antibody (Jo2) failed to coimmunoprecipi-
tate FADD from MHV-infected 17Cl-1 cell extracts (data
not shown), indicating that either DISC was not formed or
DISC formation was too weak to be detected.
Previous studies by others on anti-Fas antibody-in-
duced apoptosis in Jurkat and CEM cells showed an
unusual apoptotic pathway activation (Scaffidi et al.,
1998). It has been proposed that in these cells, called
type II cells, Fas-mediated pathway activation causes
very low levels of DISC formation, which is usually at an
undetectable level. Nevertheless, low levels of DISC for-
mation lead to activation of limited amounts of
caspase-8, which are yet sufficient to cleave Bid. Trun-
cated Bid fragments then relocate to mitochondria and
amplify the apoptotic signals by activating the mitochon-
drial pathway (Scaffidi et al., 1999). Activation of the
mitochondrial pathway subsequently efficiently activates
caspase-8, and since the major caspase-8 activation
step is downstream of mitochondria in type II cells (Scaf-
fidi et al., 1998), both caspase-8 activation and apoptosis
are blocked by overexpression of Bcl-2.
Although we could not detect the formation of DISC in
MHV-infected 17Cl-1 cells, it is possible that the upregu-
lated Fas protein activates the Fas-mediated pathway
through the same or a similar mechanism that is used in
type II cells. If this is the case, overexpression of Bcl-2
should prevent caspase-8 activation. Western blot anal-
ysis of procaspase-8 demonstrated that the majority of
procaspase-8 was cleaved in infected 17Cl-1/neo cells at
16 h p.i. (Fig. 6A). In contrast, no significant procaspase-8
cleavage occurred in infected 17Cl-1/bcl-2 cells, even at
20 h p.i. Consistent with the magnitude of procaspase-8
cleavage, extensive Bid cleavage occurred only in in-
fected 17Cl-1/neo cells late in infection; infected 17Cl-1/
bcl-2 cells showed very low levels of Bid cleavage (Fig.
6B). These data clearly showed that Bcl-2 overexpres-
sion suppressed caspase-8 activation and Bid cleavage,
and hence the major step of caspase-8 activation oc-
curred downstream of mitochondria. All our data indicate
that a mitochondria-mediated pathway played a major
regulatory role in apoptosis in MHV-infected 17Cl-1 cells.
DISCUSSION
We examined biological roles of apoptosis in MHV
replication and mechanisms of MHV-induced apoptosis
in 17Cl-1 cells. We first showed that MHV induced
caspase-dependent apoptosis in this cell line. Subse-
quent studies showed that there was no significant dif-
FIG. 5. Bid cleavage and translocation of tBid to mitochondria in
MHV-infected 17Cl-1 cells. (A) The 17Cl-1 cells were mock infected
(lanes 1 and 2) or infected with MHV at an m.o.i. of 10 (lanes 3–6). Cell
lysates were collected at the indicated times p.i., and equal amounts of
protein (40 g) from each sample were subjected to Western blot
analysis and probed for Bid. (B) Twenty-five micrograms of mitochon-
drial (M) and cytosolic (C) proteins prepared for experiments in Fig. 3B
were subjected to Western blot analysis and probed for Bid.
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ference in the production of MHV between cells treated
with the pancaspase inhibitor and cells not treated be-
fore 12 h p.i., whereas MHV titers were higher in the
former than the latter from 16 to 36 h p.i. (Fig. 1B). These
data demonstrated that pancaspase inhibitor-mediated,
prolonged cell survival supported further viral replication.
MHV-induced apoptosis in this cell culture system ap-
pears to serve as an innate host cell response to limit the
production of viral progeny. The highest MHV titer was
detected prior to the execution of apoptosis in pan-
caspase-untreated 17Cl-1 cells (Fig. 1B), suggesting that
production of infectious MHV was less efficient in the
cells that underwent apoptosis. Probably the cellular
environment in apoptotic cells was not optimal for MHV
replication.
Activation of the mitochondria-mediated pathway re-
sults in the formation of an apoptosome complex, in
which procaspase-9 undergoes autocleavage to pro-
duce the p35 fragment (Srinivasula et al., 1998; Zou et al.,
1999). Bcl-2 protein is known to maintain the integrity of
mitochondrial membranes and prevent the release of
apoptosis-activating factors, such as cytochrome c and
AIF, from mitochondria (Kluck et al., 1997; Susin et al.,
1999b; Yang et al., 1997). Therefore, production of
caspase-9 fragment p35 in MHV-infected cells and sup-
pression of apoptosis in 17Cl-1/bcl-2 cells strongly sug-
gested activation of the mitochondria-mediated pathway
in MHV-infected 17Cl-1 cells. Unexpectedly, cytochrome
c release from mitochondria, another hallmark of mito-
chondria-mediated pathway activation, was not evident
in infected 17Cl-1 cells. In addition, the other two com-
ponents of apoptosome, caspase-9 and Apaf-1, were
both found to have a mitochondrial distribution in non-
apoptotic 17Cl-1 cells. When cells underwent apoptosis
after MHV infection, most of the mitochondria-associated
procaspase-9 and Apaf-1 were cleaved, and the
caspase-9 fragment p35, which is known to be produced
in the apoptosome (Zou et al., 1999), was also found in
the mitochondrial fraction (Fig. 3B, lane 3). These data
suggested that apoptosome formation occurred in mito-
chondria, probably on the mitochondrial outer membrane
or in the intermembrane space, in MHV-infected 17Cl-1
cells. When 17Cl-1 cells were treated with etoposide, a
known reagent that activates the mitochondria-mediated
pathway (Kluck et al., 1997; Yang et al., 1997), both cyto-
chrome c and caspase-9 fragment p35 were also found
to accumulate in the mitochondrial fraction, indicating
that the formation of apoptosome in mitochondria was
not stimuli specific; rather, it was more likely to be a
unique feature of 17Cl-1 cells. Several previous studies
FIG. 6. Effect of Bcl-2 overexpression on caspase-8 activation (A) and Bid cleavage (B). 17Cl-1/neo clone 13 cells and 17Cl-1/bcl-2 clone 7 cells
were mock infected or infected with MHV at an m.o.i. of 10. At the indicated times p.i., total cell lysates were collected and 40 g of protein from each
sample was subjected to Western blot analysis and probed for (A) caspase-8, actin, and (B) Bid.
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indicate that cytochrome c accumulation in the cytosol
during apoptosis is a cell type- and inducer-dependent
phenomenon (Adachi et al., 1998; Chauhan et al., 1997;
Tang et al., 1998), and the formation of apoptosome in the
mitochondrial intermembrane space was also suggested
in a previous report (Adachi et al., 1998). Although cyto-
chrome c, Apaf-1, and procaspase-9 were present in the
mitochondria, apoptosome was not formed in untreated
17Cl-1 cells, indicating that these components are prob-
ably located in different compartments of the mitochon-
dria. We speculate that in apoptotic 17Cl-1 cells, the
mitochondrial structure may undergo certain modifica-
tions to allow the apoptosome components to interact
and form the complex. It has been shown recently that
tBid induces a striking remodeling of the mitochondrial
structure with mobilization of the cytochrome c stores in
cristae (Scorrano et al., 2002). In MHV-infected cells,
caspase-9 cleavage fragment p37 was also detected in
the mitochondrial fraction, indicating the presence of
mitochondria-associated caspase-3 activity. The pres-
ence of procaspase-3 and procaspase-9 in the mito-
chondria is not unexpected, since both procaspases
have been reported to have cytosolic and mitochondrial
distributions (Mancini et al., 1998; Susin et al., 1999a).
Based on the data shown in Figs. 2 and 3, we suspect
that the integrity of mitochondrial membranes was al-
tered in MHV-infected 17Cl-1 cells; we currently do not
know what molecule(s) caused the mitochondrial mem-
brane damage in the first place (see Fig. 7, Model 1). We
speculate that the alteration in the integrity of mitochon-
drial membranes triggered the activation of the mito-
chondria-mediated pathway. Recent studies indicated
that caspase-8 can be activated by caspase-3, probably
via caspase-6 (Slee et al., 1999; Tang et al., 2000). It is
possible that a similar or the same caspase activation
cascade occurred in MHV-infected 17Cl-1 cells. Namely,
activation of the mitochondria-mediated pathway results
in the activation of caspase-9 (Fig. 3) and caspase-3
(data not shown), which then may activate the down-
stream caspase-6 and caspase-8 (Fig. 4). Caspase-8
cleaves Bid to produce tBid fragments, which then relo-
cates to the mitochondria (Fig. 5B) to further disturb
mitochondrial membranes; translocation of tBid to the
mitochondria amplifies the mitochondrial pathway acti-
vation. In this model, the accumulation of proapoptotic
signals that cause mitochondrial damage overcomes the
antiapoptotic function of overexpressed Bcl-2 in 17Cl-1/
bcl-2 cells. Once a low level of mitochondrial pathway
activation starts in 17Cl-1/bcl-2 cells, it leads to
caspase-3 activation and subsequent Bcl-2 cleavage;
cleaved Bcl-2 does not protect the integrity of mitochon-
dria; instead, it has proapoptotic activities (Cheng et al.,
1997). A continuous increase in the amount of caspase-
3-mediated Bcl-2 cleavage and accumulation of pro-
apoptotic tBid in the mitochondrial membranes over-
whelm the antiapoptotic function of Bcl-2, ultimately lead-
ing to cell death.
The receptor-mediated apoptotic pathway is another
major pathway in activating caspase cascades. In this
pathway, DISC formation leads to caspase-8 activation.
Activated caspase-8 then activates caspase-3 and Bid.
Although caspase-8 activation and Bid cleavage did oc-
cur in MHV-infected 17Cl-1 cells (Figs. 4 and 5), it is less
likely that these two events were efficiently activated by
the direct death receptor activation, because Bcl-2 over-
expression efficiently blocked caspase-8 activation and
Bid cleavage (Fig. 6). If the receptor-mediated pathway
plays the major direct role in caspase-8 activation and
Bid cleavage, then both events should have occurred in
17Cl-1/bcl-2 cells; overexpression of Bcl-2 should block
only the mitochondria-mediated pathway, but not the
receptor-mediated pathway. Caspase-8 activation and
Bid cleavage may occur in MHV-infected 17Cl-1 cells
through either the same or a similar apoptotic mecha-
nism as that found in type II cells (Scaffidi et al., 1998,
1999) (see Fig. 7, Model 2). In this model, the increased
Fas protein in infected 17Cl-1 cells results in a very low
level of DISC formation, which we were unable to detect.
This putative low level of DISC is able to activate a
limited amount of caspase-8. Activated caspase-8 then
cleaves caspase-3 and Bid. The p15 tBid relocates to
mitochondria and activates the mitochondrial pathway.
Once the mitochondrial pathway is activated, subse-
quent activation of caspase-9, caspase-3, caspase-6,
and caspase-8 follows, as discussed above. In 17Cl-1/
bcl-2 cells, caspase-3 activated by these mechanisms
also cleaves Bcl-2, producing the proapoptotic Bcl-2
fragment. If MHV-infected 17Cl-1 cells undergo an apopt-
otic pathway similar to that in type II cells, then the
FIG. 7. Two models for the apoptotic pathway activation in MHV-
infected 17Cl-1 cells (see text for description).
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increase of Fas late in infection may play an important
role in the regulation of apoptosis.
The present study exclusively used 17Cl-1 cells to
characterize MHV-induced apoptosis in the cell culture;
hence we do not know whether similar results will be
obtained when other cell lines are used to study the
biological roles of apoptosis in MHV replication and
mechanisms of MHV-induced apoptosis. Analysis of
MHV-susceptible cell lines, including murine L2 cells
(C.-J. Chen and S. Makino, unpublished data), DBT cells
(An et al., 1999), and J774.1 cells (S. Banerjee and S.
Makino, unpublished data), demonstrated that none of
these cell lines showed apoptotic cell death based on
DNA fragmentation analysis. Studies using other MHV-
susceptible cell lines will be needed to know whether




A plaque-cloned MHV-A59 was used throughout this
study. Mouse 17Cl-1 cells (Sturman and Takemoto, 1972)
were maintained in Dulbecco’s modified Eagle’s medium
(GIBCO-BRL) containing 10% fetal calf serum. DBT cells
(Hirano et al., 1974) were used for propagation of MHV
and plaque assays.
Establishment of Bcl-2-overexpressing 17Cl-1 cell
lines
The 17Cl-1 cells at approximately 50% confluence
were transfected with either the plasmid pZipBcl-2,
which expresses the human bcl-2 gene (Levine et al.,
1993), or its parental plasmid, pZipNeo (Cepko et al.,
1984), which lacks the bcl-2 gene, using the FuGENE 6
(Roche)-mediated transfection method. The 17Cl-1 cell
clones stably transfected with pZipBcl-2 (17Cl-1/bcl-2) or
with pZipNeo (17Cl-1/neo) were selected by adding 600
g/ml of Geneticin (GIBCO-BRL) to the culture medium
for 2 weeks.
DNA fragmentation assay
Low-molecular-weight apoptotic DNA fragments were
extracted and analyzed by electrophoresis in 2% agarose
gels as previously described (An et al., 1999).
Subdiploid population detection
Apoptotic nuclei containing subdiploid DNA content
were measured by propidium iodide staining and flow
cytometry by a previously described method (Yu et al.,
1993). Briefly, detached cells and trypsinized adherent
cells were pooled, washed with phosphate-buffered sa-
line (PBS), resuspended in a low-salt stain (3% polyeth-
ylene glycol 8000, 50 g/ml propidium iodide, 0.1% Triton
X-100, 4 mM sodium citrate, 10 g/ml of RNase A), and
incubated at 37°C for 20 min. An equal volume of high-
salt stain (3% polyethylene glycol 8000, 50 g/ml pro-
pidium iodide, 0.1% Triton X-100, 400 mM sodium chlo-
ride) was then added to the cell suspension. Propidium
iodide-stained nuclei were stored at 4°C overnight be-
fore flow cytometry analysis.
Measurement of caspase-8 activity
Cellular extracts were assayed for caspase-8 activity
using a colorimetric caspase-8 substrate labeled with
p-nitroaniline (Ac-Ile-Glu-Thr-Asp-pNA; Ac-IETD-pNA). At
different times p.i., detached and adherent cells were
collected by using a rubber policeman, washed with
PBS, and resuspended in chilled lysis buffer (10 mM
Tris–HCl, pH 7.5, 10 mM NaH2PO4, 10 mM Na2HPO4, 150
mM NaCl, 1% Triton X-100). After incubation on ice for 10
min, the lysates were centrifuged at 10,000 g for 3 min at
4°C, and the supernatants were collected and protein
concentrations were determined (DC protein assay, Bio-
Rad). Fifty microliters of cell lysates containing 200 g of
protein was mixed with 50 l of 2 reaction buffer (20
mM HEPES, pH 6.8, 200 mM NaCl, 2 mM EDTA, 0.2%
CHAPS, 20% glycerol, 10 mM DTT) and 5 l of 4 mM
Ac-IETD-pNA (Biosource International). After incubation
at 37°C for 2 h in the dark, the released chromophore
was measured by determining the absorbance at 405 nm
in a 96-well plate. Background readings from cell lysates
and buffers were subtracted, and fold increase in
caspase-8 activity was determined by comparing the
readings of MHV-infected samples with those of mock-
infected samples.
Total cell lysate preparation
The 17Cl-1 cells were collected at different times p.i.
and washed once with PBS. The cell pellets were resus-
pended in triple detergent lysis buffer (50 mM Tris–HCl,
pH 8.0, 150 mM NaCl, 0.1% SDS, 1% NP-40, 0.5% sodium
deoxycholate, 1 mM EDTA) containing protease inhibi-
tors (5 g/ml each of leupeptin and pepstatin A, 10 g/ml
of aprotinin, and 1 mM phenylmethylsulfonyl fluoride)
and incubated on ice for 30 min. The cell lysates were
centrifuged at 14,000 g for 10 min at 4°C, and the super-
natants were subject to protein concentration measure-
ment (DC Protein Assay, Bio-Rad) and Western blot anal-
ysis.
Western blot analysis
Whole cell lysates prepared from cells at different
times p.i. were subjected to SDS–polyacrylamide gel
electrophoresis (SDS–PAGE) and transferred to nitrocel-
lulose or PVDF membranes (Bio-Rad). The membranes
were blocked in blocking solution (0.05% Tween 20 and
5% nonfat dry milk in PBS), incubated with primary and
secondary antibodies diluted in blocking solutions for 1 h
each, and developed with enhanced chemiluminescence
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(ECL, Amersham Pharmacia). The following mouse
monoclonal antibodies were used: anti-cytochrome c
(clone 7H8.2C12, BD Pharmingen), anti-caspase-9 (clone
5B4, StressGen), anti-procaspase-8 (clone 5D3, MBL),
and antihuman Bcl-2 (clone 124, Roche). A rat monoclo-
nal antibody was used to detect Apaf-1 (clone 13F11,
Chemicon). A rabbit polyclonal antibody against
caspase-8 (H-134, Santa Cruz Biotechnology) was used
to detect the 18-kDa cleavage fragment, and a rabbit
polyclonal antibody was used to detect Bid (a gift from
Stanley Korsmeyer, Harvard Medical School). Actin was
detected by a goat antiactin polyclonal antibody (I-19,
Santa Cruz Biotechnology). Sheep antimouse IgG (Am-
ersham Pharmacia), goat antirabbit and antirat IgGs, and
donkey antigoat IgG (Santa Cruz Biotechnology) were
used as secondary antibodies.
Effect of caspase inhibitors on apoptosis induction
and MHV growth
The 17Cl-1 or 17Cl-1/bcl-2 cells were incubated for 2 h
with 150 M Z-VAD-FMK (Enzyme System Products) prior
to MHV infection. After MHV infection at an m.o.i. of 5 for
1 h at 37°C, cells were incubated in the presence of 150
M Z-VAD-FMK for 24 h, and the drug was replenished at
24 h p.i. At different times p.i., low-molecular-weight DNA
fragments and protein were extracted from the cells and
analyzed by agarose gel electrophoresis and SDS–
PAGE, respectively. To determine MHV titers, culture fluid
samples were collected at different times p.i. and subject
to plaque assays.
Subcellular fractionation
The 17Cl-1 cells (5  107 cells) were infected with
MHV at an m.o.i. of 10 or treated with 50 M etoposide.
At different times p.i. or drug treatment, both detached
and adherent cells were collected by scraping and cen-
trifugation at 600 g for 10 min at 4°C. The cell pellets
were washed once with PBS and resuspended with 5 vol
of HIM buffer (200 mM mannitol, 70 mM sucrose, 1 mM
EGTA, 1 mM dithiothreitol, 10 mM HEPES, pH 7.5) con-
taining protease inhibitors. After 10 min on ice, cells were
disrupted with a glass Dounce homogenizer (Wheaton),
with 30 strokes of the tight pestle. The homogenates
were centrifuged twice at 1000 g for 10 min at 4°C, and
the supernatants were further centrifuged at 10,000 g for
15 min at 4°C to collect the mitochondrial pellets. The
supernatants of the 10,000 g spin were centrifuged at
100,000 g for 1 h at 4°C, and the resulting supernatants
were collected as cytosolic fractions.
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